VYGR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.61

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

-0.01

EPS Last/This Y

0.38

EPS This/Next Y

0.1

Price

3.27

Target Price

14.89

Analyst Recom

1.09

Performance Q

-17.42

Upside

-2,219.3%

Beta

1.31

Ticker: VYGR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	VYGR	3.25	0.04	0.07	8717
2026-07-14	VYGR	3.15	0.04	0.03	8950
2026-07-15	VYGR	3.19	0.04	0.02	9114
2026-07-16	VYGR	3.04	0.04	0.00	9104
2026-07-17	VYGR	3.18	0.04	0.02	9471
2026-07-20	VYGR	3.04	0.06	0.03	5830
2026-07-21	VYGR	3.12	0.05	1.30	6314
2026-07-22	VYGR	3.1	0.10	0.10	6686
2026-07-23	VYGR	3.08	0.11	0.44	6811
2026-07-24	VYGR	3.11	0.12	0.90	7003
2026-07-27	VYGR	3.1	0.17	0.06	7340
2026-07-28	VYGR	3.04	0.17	0.00	7447
2026-07-29	VYGR	3	0.17	0.22	7448
2026-07-30	VYGR	3.13	0.17	5.56	7465
2026-07-31	VYGR	3.03	0.22	0.00	7788
2026-08-03	VYGR	2.99	0.22	0.07	7799
2026-08-04	VYGR	3.13	0.22	0.05	7805
2026-08-05	VYGR	3.09	0.22	0.00	7830
2026-08-06	VYGR	3.11	0.22	0.00	7834
2026-08-07	VYGR	3.28	0.20	0.09	8388
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	VYGR	3.25	10.9	-	-1.66
2026-07-14	VYGR	3.14	10.9	-	-1.66
2026-07-15	VYGR	3.19	10.9	-	-1.66
2026-07-16	VYGR	3.04	10.9	-	-1.66
2026-07-17	VYGR	3.17	10.9	-	-1.66
2026-07-20	VYGR	3.05	10.9	-	-1.66
2026-07-21	VYGR	3.13	10.9	-	-1.66
2026-07-22	VYGR	3.10	10.9	-	-1.66
2026-07-23	VYGR	3.09	10.9	-	-1.66
2026-07-24	VYGR	3.11	10.9	-	-1.66
2026-07-27	VYGR	3.09	10.9	-	-1.66
2026-07-28	VYGR	3.04	10.9	-	-1.66
2026-07-29	VYGR	3.00	10.9	-	-1.66
2026-07-30	VYGR	3.13	10.9	-	-1.66
2026-07-31	VYGR	3.03	10.9	-	-1.66
2026-08-03	VYGR	3.00	10.9	-	-1.66
2026-08-04	VYGR	3.00	10.9	-	-1.66
2026-08-05	VYGR	3.08	10.9	-	-1.66
2026-08-06	VYGR	3.12	10.9	-	-1.66
2026-08-07	VYGR	3.27	10.9	-	-1.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	VYGR	-0.79	-2.54	7.09
2026-07-14	VYGR	-0.79	-2.54	7.09
2026-07-15	VYGR	-0.79	-2.54	7.09
2026-07-16	VYGR	-0.79	-2.54	7.09
2026-07-17	VYGR	-0.79	-2.54	7.09
2026-07-20	VYGR	-0.79	-2.54	7.09
2026-07-21	VYGR	-0.79	-2.54	7.09
2026-07-22	VYGR	-0.79	-2.54	7.09
2026-07-23	VYGR	-0.79	-2.54	7.09
2026-07-24	VYGR	-0.79	-2.54	7.09
2026-07-27	VYGR	-0.79	-2.88	7.61
2026-07-28	VYGR	-0.79	-2.88	7.61
2026-07-29	VYGR	-0.79	-2.88	7.61
2026-07-30	VYGR	-0.79	-2.88	7.61
2026-07-31	VYGR	-0.79	-2.88	7.61
2026-08-03	VYGR	-0.79	-3.56	7.61
2026-08-04	VYGR	-0.79	-3.56	7.61
2026-08-05	VYGR	-0.79	-3.56	7.61
2026-08-06	VYGR	-0.79	-3.56	7.61
2026-08-07	VYGR	-0.79	-3.56	7.61
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.47

Avg. EPS Est. Current Quarter

-0.51

Avg. EPS Est. Next Quarter

-0.48

Insider Transactions

-0.79

Institutional Transactions

-3.56

Beta

1.31

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

77.2

Max Drawdown 5-Year %

-80.5

Target Price

14.89

P/E

Forward P/E

PEG

P/S

5.41

P/B

1.14

P/Free Cash Flow

EPS

-1.98

Average EPS Est. Cur. Y

-1.66

EPS Next Y. (Est.)

-1.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-319.61

Relative Volume

0.73

Return on Equity vs Sector %

-94.5

Return on Equity vs Industry %

-78.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.07

EBIT Estimation

◆ VYGR Healthcare

$3.27

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

11/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

51.9

Range 1M

38.7%

Sup Dist

5.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

17/30

Estimates

0/20

Inst/Vol

1/15

Options

10/10

EPS Yr

16.9%

EPS NY

20%

52W%

12.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +355.4% upside

Quality

6/30

Valuation

16/30

Growth

11/25

Stability

6/10

LT Trend

1/5

Upside

+355.4%

Quality

VYGR — P/E HistoricalBiotechnology

Voyager Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 141

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

VYGR

Latest News

—

Caricamento notizie per VYGR…

stock quote shares VYGR – Voyager Therapeutics, Inc. Stock Price stock today

news today VYGR – Voyager Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VYGR – Voyager Therapeutics, Inc. yahoo finance google finance

stock history VYGR – Voyager Therapeutics, Inc. invest stock market

stock prices VYGR premarket after hours

ticker VYGR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VYGR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y